Sexually transmitted infections

Sexually transmitted infections features

• 

  Saving face: GMFA's sexual health messaging service

  Gay men’s health charity, GMFA, is launching a new service to make telling sexual partners about STIs less daunting. Gus Cairns investigates. ...

  From:HIV treatment update

Sexually transmitted infections in your own words

• 

  A problem below stairs...

  I’ve had warts since I was a child – they run in my family. At one point, around the age of 12, I had small...

  From:In your own words

• 

  Bored and horny

  It’s Sunday afternoon and it’s raining. I’m bored and horny. However, I’ve got £20 left over from the night before and this will be enough...

  From:In your own words

Sexually transmitted infections news from aidsmap

• US CDC recommends HPV vaccine for young men

  Young men and adolescent boys between the ages of 11 and 21 should be vaccinated against human papillomavirus, the cause of genital warts, anal and cervical cancer, the Advisory Committee on Immunization Practices has recommended, in a new Adult ...

  06 February 2012 | Keith Alcorn

• Gardasil protects against recurrence of pre-cancerous anal lesions in HIV-negative gay men

  The genital wart vaccine Gardasil significantly reduces the risk of high-grade pre-cancerous anal lesion recurrence in men who have sex with men, US investigators report in the online edition of Clinical Infectious Diseases. The vaccine reduced the risk of lesion recurrence ...

  06 February 2012 | Michael Carter

• Antiviral treatment doesn't prevent short episodes of genital herpes reactivation

  High-dose antiviral treatment does not prevent short, sub-clinical shedding of the genital herpes virus, investigators from the US report in the January 5 edition of The Lancet. “Our results show that short episodes of subclinical shedding persist with both standard-dose ...

  06 January 2012 | Michael Carter

• High rate of new diagnoses when gay men phoned and asked to come back for sexual health check-up

  It’s feasible for sexual health clinics to take steps to invite ‘high-risk’ patients to come back for re-screening, and doing so leads to a high number of new diagnoses being made, London clinicians report in the December issue of ...

  05 December 2011 | Roger Pebody

• LGV cases almost triple in one year; UK public health officials warn against serosorting

  The number of gay men infected with the sexually transmitted infection lymphogranuloma venereum (LGV) has almost tripled in one year, and the UK now has the world’s worst epidemic of LGV, the Health Protection Agency reported ...

  29 November 2011 | Roger Pebody

• Anal HPV infection more likely to persist in gay men compared to heterosexual men

  An international team of investigators have found a possible explanation for the higher rates of anal cancer observed in men who have sex with men (MSM) compared to men who have sex with women (MSW). In the December ...

  03 November 2011 | Michael Carter

• Reduced susceptibility to first-line drug causes change in UK gonorrhoea prescribing practice

  UK Prescribing guidance for the treatment of gonorrhoea needs to change because of increasing prevalence of bacteria with reduced susceptibility to the first-line antibiotic cefixime, the Health Protection Agency (HPA) has announced.  Some 17% of gonorrhoea samples tested ...

  11 October 2011 | Michael Carter

• Herpes drugs and viral load: valaciclovir works better than aciclovir

  The anti-herpes drug valaciclovir (Valtrex, valacyclovir in the US) produced a 17-fold (1.23 log) reduction in HIV viral load in Kenyan patients not taking treatment, the sixth International AIDS Society conference (IAS 2011) in Rome heard last Wednesday. Last Monday, ...

  26 July 2011 | Gus Cairns

• Daily aciclovir slows HIV disease progression and reduces viral load

  Daily treatment with standard-dose aciclovir delays HIV disease progression and lowers viral load in patients co-infected with herpes simplex virus-2 (HSV-2), results of a study presented to the Sixth International AIDS Conference (IAS 2011) in Rome show. Two more ...

  19 July 2011 | Michael Carter

• Bacterial vaginosis raises women's risk of transmitting HIV

  A man who is in a relationship with an HIV-positive woman has a three times higher risk of acquiring HIV if his partner also has bacterial vaginosis, Craig Cohen told the Sixth International AIDS Society conference (IAS 2011) in ...

  18 July 2011 | Roger Pebody

More news

Sexually transmitted infections news selected from other sources

• Antibiotics Losing Battle Against Gonorrhea

  The last line of defense against gonorrhea is losing its effectiveness against the gonorrhea, according to a new article published February 9 in the The New England Journal of Medicine.

  09 February 2012 | AIDSMeds

• CDC: 22.6% of Sexually Active Teenagers Are Tested for HIV

  Less than a quarter of teenagers who have had sex have been tested for HIV, according to researchers from the US Centers for Disease Control and Prevention (CDC), who published their findings online January 2 in the Archives of Pediatric and Adolescent Medicine.

  05 January 2012 | Medscape (requires registration)

• Herpes Vaccine Fails to Protect Women

  A once-promising vaccine against herpes viruses has failed in a large clinical trial, researchers reported.

  05 January 2012 | MedPage Today

• UK switches to Merck's Gardasil for HPV vaccination

  Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil.

  26 November 2011 | Reuters

• Syphilis Increase in U.S. Leads to Call for More Screenings

  Cases of syphilis, once on the verge of elimination, rose 36 percent in the U.S. in four years and more than doubled in young, homosexual black men, leading health authorities to recommend more frequent screening.

  18 November 2011 | San Francisco Chronicle

• HPV Vaccine Protection Against Anal Disease in Men - Controversy About Meaning of Results

  In young men who have sex with men (MSM), the human papillomavirus (HPV) quadrivalent vaccine (Gardasil, Merck) reduced the rates of anal intraepithelial neoplasia (AIN), compared with placebo, according to an international team of investigators.

  31 October 2011 | Medscape (requires free registration)

• Panel Endorses HPV Vaccine for Boys of 11

  Boys and young men should be vaccinated against human papillomavirus, or HPV, to protect against anal and throat cancers that can result from sexual activity, a federal advisory committee said Tuesday.

  27 October 2011 | New York Times

• Clinical trial shows first evidence that anal cancer is preventable

  (University of California - San Francisco) A large, international clinical trial led by doctors at the University of California, San Francisco indicates that a vaccine to prevent anal cancer is safe and effective, according to a study reported in the Oct. 27, 2011 issue of New England Journal of Medicine.

  26 October 2011 | Eurekalert Medicine & Health

• Panel recommends HPV shot in boys

  A US government medical panel recommends the human papillomavirus vaccine for boys, as vaccination rates for young women stagnate.

  26 October 2011 | BBC Health

• Gel Cuts Women’s Risk of Herpes, Study Finds

  A vaginal gel that sharply reduces a woman’s risk of infection with the AIDS virus is even more effective against genital herpes, a much more common risk for young American women, a new study has found.

  21 October 2011 | New York Times

More news